Inventor · disambiguated record
Jack Henkin
Also filed as: HENKIN JACK
17 granted patents·25 pending applications·316 citations·filing 1998–2021
94Inventor score
Top patents by PatentIndex Score
42 records- 0194US7030262B23-Amino-2-hydroxyalkanoic acids and their prodrugsABBOTT LAB·Filed 2003·Granted Apr 18, 2006·42 cites·4 claims
- 0292US6288228B1Triazine angiogenesis inhibitorsABBOTT LAB·Filed 2000·Granted Sep 11, 2001·37 cites·12 claims
- 0390US7491718B2Sulfonamides having antiangiogenic and anticancer activityABBOTT LAB·Filed 2003·Granted Feb 17, 2009·35 cites·3 claims
- 0488US5932545AAntiangiogenic drug to treat cancer, arthritis and retinopathyABBOTT LAB·Filed 1998·Granted Aug 3, 1999·73 cites·34 claims
- 0587US6242494B1Substituted β-amino acid inhibitors of methionine aminopeptidase-2ABBOTT LAB·Filed 1999·Granted Jun 5, 2001·47 cites·15 claims
- 0684US10583199B2Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugsUNIV NORTHWESTERN·Filed 2017·Granted Mar 10, 2020·2 cites·19 claims
- 0783US6774211B1Peptide antiangiogenic drugsABBOTT LAB·Filed 2001·Granted Aug 10, 2004·10 cites·12 claims
- 0880US6849757B2Antiangiogenic drug to treat cancer, arthritis and retinopathyABBOTT LAB·Filed 2003·Granted Feb 1, 2005·9 cites·4 claims
- 0975US6777535B1N-alkylated peptides having antiangiogenic activityABBOTT LAB·Filed 2000·Granted Aug 17, 2004·3 cites·38 claims
- 1073US6753408B1Peptides having antiangiogenic activityFiled 2000·Granted Jun 22, 2004·3 cites·29 claims
- 1172US6632961B1Antiangiogenic drug to treat cancer, arthritis and retinopathyABBOTT LAB·Filed 1999·Granted Oct 14, 2003·12 cites·5 claims
- 1271US6150362ATriazine angiogenesis inhibitorsFiled 1998·Granted Nov 21, 2000·27 cites·3 claims
- 1371US2008227701A1Antiangiogenic polypeptides and methods for inhibiting angiogenesisHENKIN JACK·Filed 2007·Application pending·0 cites
- 1470US10081668B2Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotectionUNIV NORTHWESTERN·Filed 2017·Granted Sep 25, 2018·1 cites·19 claims
- 1567US2022096656A1Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugsUNIV NORTHWESTERN·Filed 2021·Application pending·0 cites
- 1667US2007043089A1Method of inhibiting angiogenesisHAVIV FORTUNA·Filed 2006·Application pending·0 cites
- 1767US2007032527A1Method of inhibiting angiogenesisHAVIV FORTUNA·Filed 2006·Application pending·0 cites
- 1866US11207423B2Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugsUNIV NORTHWESTERN·Filed 2020·Granted Dec 28, 2021·0 cites·19 claims
- 1966US6716963B1Peptide antiangiogenic drugsABBOTT LAB·Filed 1999·Granted Apr 6, 2004·15 cites·42 claims
- 2062US2004116479A1Method of inhibiting angiogenesisFiled 2003·Application pending·0 cites
- 2161US2004132664A1Antiangiogenic polypeptides and methods for inhibiting angiogenesisFiled 2004·Application pending·0 cites
- 2260US11261237B2Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotectionUNIV NORTHWESTERN·Filed 2018·Granted Mar 1, 2022·0 cites·25 claims
- 2358US2005124548A1Peptide antiangiogenic drugsFiled 2004·Application pending·0 cites
- 2457US2008004222A1Antitumorigenic Drug CombinationHENKIN JACK·Filed 2007·Application pending·0 cites
- 2555US2002159992A1Antiangiogenic polypeptides and methods for inhibiting angiogenesisFiled 2001·Application pending·0 cites
- 2654US2011218150A1Antiangiogenic polypeptides and methods for inhibiting angiogenesisABBOTT LAB·Filed 2011·Application pending·0 cites
- 2753US7432245B2Pharmaceutical formulation comprising a peptide angiogenesis inhibitorABBOTT LAB·Filed 2003·Granted Oct 7, 2008·0 cites·16 claims
- 2849US2006030557A1Substituted pyridines having antiangiogenic activityHAVIV FORTUNA·Filed 2005·Application pending·0 cites
- 2949US2003045477A1Peptides having antiangiogenic activityFiled 2002·Application pending·0 cites
- 3048US2004014744A1Substituted pyridines having antiangiogenic activityFiled 2003·Application pending·0 cites
- 3147US2008027008A1Antitumorigenic Drug CombinationHENKIN JACK·Filed 2007·Application pending·0 cites
- 3247US2003195195A1Substituted pyridines having antiangiogenic activityFiled 2002·Application pending·0 cites
- 3346US2003195192A1Nicotinamides having antiangiogenic activityFiled 2002·Application pending·0 cites
- 3444US2006258597A1Antitumorigenic drug combination and dosing scheduleHENKIN JACK·Filed 2006·Application pending·0 cites
- 3544US2004077031A1Novel methionine aminopeptidase-2 and uses thereofFiled 2002·Application pending·0 cites
- 3641US2004067985A1Method of inhibiting angiogenesisFiled 2002·Application pending·0 cites
- 3740US2003050246A1Peptides having antiangiogenic activityFiled 2001·Application pending·0 cites
- 3838US2004068012A1Sulfonamides having antiangiogenic and anticancer activityFiled 2002·Application pending·0 cites
- 3938US2002183242A1Peptide antiangiogenic drugsFiled 2001·Application pending·0 cites
- 4037US2004157836A1Sulfonamides having antiangiogenic and anticancer activityFiled 2003·Application pending·0 cites
- 4136US2003228365A1Pharmaceutical formulationFiled 2002·Application pending·0 cites
- 4227US2002106775A1Highly crystalline urokinaseFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jack Henkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →